Articles

FDA’s $6.4B drug review fee plan passes Senate

The U.S. Senate voted to let regulators collect on a $6.4 billion fee agreement struck with Indianapolis-based Eli Lilly and Co., Medtronic Inc. and other companies to fund reviews of new drugs and medical devices through 2017.

Read More

Mexican big rigs shun border, imperiling trucking deal

A cross-border trucking pact that ended a 17-year trade dispute between the U.S. and Mexico last year may unravel unless more Mexican big rigs start crossing the border. Failure of the program could have an impact on trucking firms like Indianapolis-based Celadon Group Inc.

Read More

Student-loan debt-collection agencies garner criticism

Lucrative incentives paid to federal student-loan collectors are sparking criticism that not-for-profit loan-guaranty agencies are reaping a bonanza from the troubles of former students. USA Funds, the largest guaranty agency, is based in Indianapolis.

Read More

Cancer tools help Roche with Alzheimer’s drug

Treatments for central nervous system diseases have a huge potential payoff, analysts say. A hint of whether the gamble may pay off is due in the second half of this year, as Eli Lilly and Co. and Pfizer Inc. announce results for Alzheimer’s drugs that attack the same protein as Roche’s experimental drug.

Read More

U.S. jobless rate slips despite dismal employment report

Employers added fewer workers than predicted in April, but the jobless rate unexpectedly fell as workers left the labor force. The participation rate, which indicates the share of working-age people in the labor force, fell to it lowest mark since 1981.

Read More

Arrests made in $80M Lilly prescription drug heist

Authorities have arrested two Cuban brothers in the 2010 theft of about $80 million in Eli Lilly and Co. prescription drugs from a Connecticut warehouse, a robbery described as one of the biggest pharmaceutical heists in history, the U.S. attorney’s office said Thursday.

Read More